Stereoelectronic properties of antimalarial artemisinin analogues in relation to neurotoxicity

Chemical Research in Toxicology

Volumn 12, Issue 5, 1999, Pages 422-428

  Bhattacharjee, Apurba K ^a   Karle, Jean M ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEETHER; ARTELINIC ACID; ARTEMETHER; ARTEMISININ DERIVATIVE; DEOXOARTEMISININ; DIHYDROARTEMISININ;

ANIMAL EXPERIMENT; ARTICLE; DRUG CONFORMATION; DRUG SOLUBILITY; LIPID SOLUBILITY; MOUSE; NEUROTOXICITY; NONHUMAN; QUANTUM CHEMISTRY; STEREOISOMERISM; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TOXICITY TESTING;

ANIMALS; ANTIMALARIALS; ARTEMISININS; BICYCLO COMPOUNDS, HETEROCYCLIC; CHEMISTRY, PHYSICAL; MICE; MOLECULAR CONFORMATION; NEUROTOXINS; PEROXIDES; PROTONS; RATS; SESQUITERPENES; SOLUBILITY; STEREOISOMERISM; SUCCINATES; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0032781427     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx9802116     Document Type: Article

References (49)

1. Kondrachine, A. V., and Trigg, P. I. (1997) Global overview of malaria. Indian J. Med. Res. 106, 39-52.
2. White, N. J. (1992) Antimalarial drug resistance: the pace quickens. J. Antimicrob. Chemother. 30, 571-585.
3. Milhous, W. K., and Kyle, D. E. (1998) Introduction to the modes of action and mechanisms of resistance to antimalarial drugs. In Malaria: Parasite Biology, Pathogens, and Protection (Sherman, I. W., Ed.) pp 303-316, American Society for Microbiology, Washington, DC.
4. Quinghao Antimalarial Coordinating Research Group (1979) Chin. Med. J. 92, 811-816.
5. Butler, A. R., and Wu, Y. L. (1992) Artemisinin (qinghaosu): a new type of antimalarial drug. Chem. Soc. Rev. 21, 85-90.
6. Qinghaosu Research Group (1980) Crystal structure and absolute configuration of qinghaosu. Scientia Sinica 23, 380-396.
7. Jefford, C. W. (1997) Peroxidic antimalarials. Adv. Drug Res. 29, 271-325.
8. Cumming, J. N., Ploypradith, P., and Posner, G. (1996) Malaria chemotherapy using 1,2,4-trioxane related to artemisinin: molecular mechanism(s) of action. Adv. Pharmacol. 37, 253-297.
9. Meshnick, S. R., Taylor, T. E., and Kamchonwongpaisan, S. (1996) Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol. Rev. 60, 301-315.
10. McIntosh, H. M., and Olliaro, P. (1998) Artemisinin derivatives in the treatment of severe malaria. In Infectious Diseases Module of the Cochrane Database of Systematic Reviews (Garner, P., Gelband, H., Olliaro, P., Salinas, R., Volmink, J., and Wilkinson, D., Eds.) The Cochrane Library, BMJ Publishing, London.
11. Brewer, T. G., Grate, S. J., Peggins, J. O., Weina, P. J., Petras, J. M., Levine, B. S., Heiffer, M. H., and Schuster, B. G. (1994) Fatal neurotoxicity of arteether and artemether. Am. J. Trop. Med. Hyg. 51, 251-259.
12. Petras, J. M., Kyle, D. E., Gettayacamin, M., Young, G. D., Bauman, R. A., Webster, H. K., Corcoran, K. D., Peggins, J. O., Vane, M. A., and Brewer, T. G. (1997) Arteether: risks of two-week administration in macaca mulatta. Am. J. Trop. Med. Hyg. 56, 251-259.
13. Kamchonwongpaisan, S., McKeever, P., Hossler, P., Ziffer, H., and Meshnick, S. R. (1997) Artemisinin neurotoxicity: neuropathology in rats and mechanistic studies in vitro. Am. J. Trop. Med. Hyg. 56, 7-12.
14. Smith, S. L., Fishwick, J., Mclean, W. G., Edwards, G., and Ward, S. A. (1997) Enhanced in vitro neurotoxicity of artemisinin derivatives in the presence of haemin. Biochem. Pharmacol. 53, 5-10.
15. Wesche, D. L., DeCoster, M. A., Tortella, F. C., and Brewer, T. G. (1994) Neurotoxicity of artemisinin analogs in vitro. Antimicrob. Agents Chemother. 38, 1813-1819.
16. Thomson, C., Cory, M., and Zerner, M. (1991) Theoretical studies of some new antimalarial drugs. Int. J. Quantum Chem. 18, 231-245.
17. Bernardinelli, G., Jefford, C. W., Marie, D., Thomson, C., and Weber, J. (1994) Computational studies of the structures and properties of potential antimalarial compounds based on the 1,2,4-trioxane ring structure. I. Artemisinin-like molecules. Intl. J. Quantum Chem. 21, 117-131.
18. Bhattacharjee, A. K., and Karle, J. M. (1996) Molecular electronic properties of a series of 4-quinolinemethanolamines define anti-malarial activity profile. J. Med. Chem. 39, 4622-4629.
19. Bhattacharjee, A. K., and Karle, J. M. (1998) Functional correlation of molecular electronic properties with potency of synthetic carbinolamine antimalarial agents. Bioorg. Med. Chem. 6, 1927-1933.
20. SPARTAN, version 5.0 (1997) Wavefunction, Inc., Irvine, CA.
21. Frisch, M. J., Trucks, G. W., Schlegel, H. B., Gill, P. M. W., Johnson, B. G., Robb, M. A., Cheeseman, J. R., Keith, T. A., Petersson, G. A., Montgomery, J. A., Raghavachari, K., Al-Laham, M. A., Zakrzewski, V. G., Ortiz, J. V., Foresman, J. B., Cioslowski, J., Stefanov, B. B., Nanayakkara, A., Challacombe, M., Peng, C. Y., Ayala, P. Y., Chen, W., Wong, M. W., Andres, J. L., Replogle, E. S., Gomperts, R., Martin, R. L., Fox, D. J., Binkley, J. S., Defrees, D. J., Baker, J., Stewart, J. P., Head-Gordon, M., Gonzalez, C., and Pople, J. A. (1995) Gaussian 94 (Revision A.1), Gaussian, Inc., Pittsburgh, PA.
22. Dixon, R. W., Leonard, J. M., and Hehre, W. J. A. (1993) Continuum solvation model for the AM1 semi-empirical method. Isr. J. Chem. 33, 427-434.
23. Luo, X., Yeh, H. J. C., Brossi, A., Flippen-Anderson, J. L., and Gilardi, R. (1984) Configurations of antimalarials derived from qinghaosu: dihydroqinghaosu, artemether, and artesunic acid. Helv. Chim. Acta 67, 1515-1522.
24. Acton, N., Karle, J. M., and Miller, R. E. (1993) Synthesis and antimalarial activity of some 9-substituted artemisinin derivatives. J. Med. Chem. 36, 2552-2557.
25. Leban, I., Golic, L., and Japelj, M. (1988) Crystal and molecular structure of qinghaosu: a redetermination. Acta Pharm. Jugosl. 38, 71-77.
26. Karelson, M., Lobanov, V. S., and Katrinsky, A. R. (1996) Quantum-chemical descriptors in QSAR/QSPR studies. Chem. Rev. 96, 1027-1044.
27. 2 receptors. In Recent Advances in Receptor Chemistry (Melchiorre, C., and Giannella, M., Eds.) pp 289-306, Elsevier Science Publishers, Amsterdam.
28. Tsuji, A., and Tamai, I. (1998) Blood-brain barrier transport of drugs. In Introduction to the Blood-Brain Barrier: Methodology, Biology, and Pathology (Pardridge, W. M., Ed.) pp 238-247, Cambridge University Press, Cambridge, U.K.
29. Naray-Szabo, G., and Balogh, T. (1993) Viewpoint 7: The average molecular electrostatic field as a QSAR descriptor. Part 4. Hydrophobicity scales for amino acid residues. THEOCHEM 284, 243-248.
30. Du, Q., and Arteca, G. A. (1996) Modeling lipophilicity from the distribution of electrostatic potential on a molecular surface. J. Comput.-Aided Mol. Des. 10, 133-144.
31. Cronin, M. T. D. (1996) Quantitative structure-activity relationship (QSAR) analysis of the acute sublethal neurotoxicity of solvents. Toxicol. in Vitro 10, 103-110.
32. van de Waterbeemd, H., and Kansy, M. (1992) Hydrogen-bonding capacity and brain penetration. Chimica 46, 299-303.
33. Norinder, U., Sjoberg, P., and Osterberg T. (1998) Theoretical calculation and prediction of blood-brain partitioning of organic solutes using MolSurf parametrization and PLS statistics. J. Pharm. Sci. 87, 952-959.
34. Murray, J. S., Zilles, B. A., Jayasuriya, K., and Politzer, P. (1986) Comparative analysis of the electrostatic potentials of dibenzofuran and some dibenzo-p-dioxins. J. Am. Chem. Soc. 108, 915-918.
35. Pearson, R. G. (1989) Absolute electronegativity and hardness: applications to organic chemistry. J. Org. Chem. 54, 1423-1430.
36. Lombardo, F., Blake, J. F., and Curatolo, W. J. (1996) Computation of brain-blood partitioning of organic solutes via free energy calculations. J. Med. Chem. 39, 4750-4755.
37. Lin, A. J., Klayman, D. L., and Milhous, W. K. (1987) Antimalarial activity of new water-soluble dihydroartemisinin derivatives. J. Med. Chem. 30, 2147-2150.
38. Benakis, A., Paris, M., Loutan, L., Plessas, C. T., and Plessas, S. T. (1997) Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers. Am. J. Trop. Med. Hyg. 56, 17-23.
39. Li, Q. G., Peggins, J. O., Fleckenstein, L. L., Masonic, K., Heiffer, M. H., and Brewer, T. G. (1998) The pharmacokinetics and bioavailability of dihydroartemisinin, arteether, artemether, artesunic acid and artelinic acid in rats. J. Pharm. Pharmacol. 50, 1-11.
40. Leskovac, V., and Theoharides, A. D. (1991) Hepatic metabolism of artemisinin drugs. 1. Drug metabolism in rat liver microsomes. Comput. Biochem. Physiol. 99C, 383-390.
41. Leskovac, V., and Theoharides, A. D. (1991) Hepatic metabolism of artemisinin drugs. 2. Drug metabolism in rat liver microsomes. Comput. Biochem. Physiol. 99C, 391-396.
42. Fishwick, J., McLean, W. G., Edwards, G., and Ward, S. A. (1995) The toxicity of artemisinin and related compounds on neuronal and glial cells in culture. Chem.-Biol. Interact. 96, 263-271.
43. Brossi, A., Venugopalan, B., Dominguez Gerpe, L., Yeh, H. J. C., Flippen-Anderson, J. L., Buchs, P., Luo, X. D., Milhous, W., and Peters, W. (1988) Arteether, a new antimalarial drug: synthesis and antimalarial properties. J. Med. Chem. 31, 645-650.
44. Jung, M., Li, X., Bustos, D. A., ElSohly, H. N., McChesney, J. D., and Milhous, W. K. (1990) Synthesis and antimalarial activity of (+)-deoxoartemisinin. J. Med. Chem. 33, 1516-1518.
45. Lin, A. J., and Miller, R. E. (1995) Antimalarial activity of new dihydroartemisinin derivatives. 6. α-alkylbenzylic ethers. J. Med. Chem. 38, 764-770.
46. Chemical Information System (1997) Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Washington, DC.
47. MacLogP, version 2.5 (1998) Biobyte Corp., Claremont, CA.
48. 2 receptor histamine antagonists. J. Med. Chem. 31, 656-671.
49. Seiler, P. (1974) Interconversion of lipophilicities from hydrocarbon/water systems into the octanol/water system. Eur. J. Med. Chem. 9, 473-479.